Novel Therapies for ANCA-associated Vasculitis: Apilimod Ameliorated Endothelial Cells Injury through TLR4/NF-κB Pathway and NLRP3 Inflammasome
Article in Current Pharmaceutical Design (June 2024)
The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.
Article in Current Pharmaceutical Design (June 2024)
Article in Frontiers in Pharmacology (May 2024)
Article in Current Rheumatology Reviews (January 2024)